Sökning: WFRF:(Maestre Gladys E.) >
Outcome-Driven Thre...
-
Cheng, Yi-BangShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China
(författare)
Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New American College of Cardiology/American Heart Association Classification of Hypertension
- Artikel/kapitelEngelska2019
Förlag, utgivningsår, omfång ...
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-395430
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-395430URI
-
https://doi.org/10.1161/HYPERTENSIONAHA.119.13512DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
The new American College of Cardiology/American Heart Association guideline reclassified office blood pressure and proposed thresholds for ambulatory blood pressure (ABP). We derived outcome-driven ABP thresholds corresponding with the new office blood pressure categories. We performed 24-hour ABP monitoring in 11 152 participants (48.9% women; mean age, 53.0 years) representative of 13 populations. We determined ABP thresholds resulting in multivariable-adjusted 10-year risks similar to those associated with elevated office blood pressure (120/80 mm Hg) and stages 1 and 2 of office hypertension (130/80 and 140/90 mm Hg). Over 13.9 years (median), 2728 (rate per 1000 person-years, 17.9) people died, 1033 (6.8) from cardiovascular disease; furthermore, 1988 (13.8), 893 (6.0), and 795 (5.4) cardiovascular and coronary events and strokes occurred. Using a composite cardiovascular end point, systolic/diastolic outcome-driven thresholds indicating elevated 24-hour, daytime, and nighttime ABP were 117.9/75.2, 121.4/79.6, and 105.3/66.2 mm Hg. For stages 1 and 2 ambulatory hypertension, thresholds were 123.3/75.2 and 128.7/80.7 mm Hg for 24-hour ABP, 128.5/79.6 and 135.6/87.1 mm Hg for daytime ABP, and 111.7/66.2 and 118.1/72.5 mm Hg for nighttime ABP. ABP thresholds derived from other end points were similar. After rounding, approximate thresholds for elevated 24-hour, daytime, and nighttime ABP were 120/75, 120/80, and 105/65 mm Hg, and for stages 1 and 2, ambulatory hypertension 125/75 and 130/80 mm Hg, 130/80 and 135/85 mm Hg, and 110/65 and 120/70 mm Hg. Outcome-driven ABP thresholds corresponding to elevated blood pressure and stages 1 and 2 of hypertension are similar to those proposed by the current American College of Cardiology/American Heart Association guideline.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Thijs, LutgardeUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(författare)
-
Zhang, Zhen-YuUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(författare)
-
Kikuya, MasahiroTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan
(författare)
-
Yang, Wen-YiUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(författare)
-
Melgarejo, Jesus D.Univ Zulia, Lab Neurociencias, Maracaibo, Venezuela; Univ Zulia, Inst Enfermedades Cardiovasc, Maracaibo, Venezuela
(författare)
-
Boggia, JoseUniv Republica, Hosp Clin, Ctr Nefrol, Montevideo, Uruguay; Univ Republica, Hosp Clin, Dept Fisiopatol, Montevideo, Uruguay
(författare)
-
Wei, Fang-FeiUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(författare)
-
Hansen, Tine W.Steno Diabet Ctr, Gentofte, Denmark;Ctr Hlth, Gentofte, Capital Region, Denmark
(författare)
-
Yu, Cai-GuoUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(författare)
-
Asayama, KeiTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan;Tohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan
(författare)
-
Ohkubo, TakayoshiTeikyo Univ, Dept Hyg & Publ Hlth, Sch Med, Tokyo, Japan;Tohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan
(författare)
-
Dolan, EamonStroke & Hypertens Unit, Dublin, Ireland
(författare)
-
Stolarz-Skrzypek, KatarzynaJagiellonian Univ, Med Coll, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland
(författare)
-
Malyutina, SofiaRussian Acad Sci, Inst Internal & Prevent Med, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia
(författare)
-
Casiglia, EdoardoUniv Padua, Dept Med, Padua, Italy
(författare)
-
Lind, LarsUppsala universitet,Geriatrik,Uppsala Univ, Sect Geriatr, Dept Publ Hlth & Caring Sci, Uppsala, Sweden(Swepub:uu)larslind
(författare)
-
Filipovsky, JanCharles Univ Prague, Fac Med, Plzen, Czech Republic
(författare)
-
Maestre, Gladys E.Univ Zulia, Lab Neurociencias, Maracaibo, Venezuela; Univ Zulia, Inst Enfermedades Cardiovasc, Maracaibo, Venezuela; Univ Texas Rio Grande Valley, Sch Med, Dept Neurosci, Brownsville, TX USA; Univ Texas Rio Grande Valley, Sch Med, Dept Human Genet, Brownsville, TX USA
(författare)
-
Imai, YutakaTohoku Inst Management Blood Pressure, Dept Planning Drug Dev & Clin Evaluat, Sendai, Miyagi, Japan
(författare)
-
Kawecka-Jaszcz, KalinaJagiellonian Univ, Med Coll, Dept Cardiol Intervent Electrocardiol & Hypertens, Krakow, Poland
(författare)
-
Sandoya, EdgardoAsociac Espanola Primera Socorros Mutuos, Montevideo, Uruguay
(författare)
-
Narkiewicz, KrzysztofMed Univ Gdansk, Dept Hypertens & Diabetol, Hypertens Unit, Gdansk, Poland
(författare)
-
Li, YanShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China
(författare)
-
O'Brien, EoinUniv Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin, Ireland
(författare)
-
Wang, Ji-GuangShanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R China
(författare)
-
Staessen, Jan A.Univ Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium; Maastricht Univ, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands
(författare)
-
Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Shanghai Inst Hypertens, Shanghai Key Lab Hypertens, Ctr Vasc Evaluat,Ruijin Hosp,Sch Med, Shanghai, Peoples R ChinaUniv Leuven, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven, Dept Cardiovasc Sci, Leuven, Belgium
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Hypertension74:4, s. 776-7830194-911X1524-4563
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Cheng, Yi-Bang
-
Thijs, Lutgarde
-
Zhang, Zhen-Yu
-
Kikuya, Masahiro
-
Yang, Wen-Yi
-
Melgarejo, Jesus ...
-
visa fler...
-
Boggia, Jose
-
Wei, Fang-Fei
-
Hansen, Tine W.
-
Yu, Cai-Guo
-
Asayama, Kei
-
Ohkubo, Takayosh ...
-
Dolan, Eamon
-
Stolarz-Skrzypek ...
-
Malyutina, Sofia
-
Casiglia, Edoard ...
-
Lind, Lars
-
Filipovsky, Jan
-
Maestre, Gladys ...
-
Imai, Yutaka
-
Kawecka-Jaszcz, ...
-
Sandoya, Edgardo
-
Narkiewicz, Krzy ...
-
Li, Yan
-
O'Brien, Eoin
-
Wang, Ji-Guang
-
Staessen, Jan A.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Hypertension
- Av lärosätet
-
Uppsala universitet